Analyst Ratings for Bristol-Myers Squibb Co. (BMY)

BMY Rating Summary

BMY Price Target Summary

* Over Last 12-Mos
  |   Expand Research on BMY
Overall Rating: NEUTRAL   Rating Trend: Up   Avg. $ Target: $72.55 (+11.8%) * Over Last 12-Mos
Rating Score: 5.3 / 10   Percentile Rank: 55%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
4/30/2021 Morgan Stanley David Risinger Downgrade Equalweight
(Overweight)
62.00
(70.00)
66.03
(64.88)
-1.74% Details
4/13/2021 Truist Securities Gregg Gilbert Upgrade Buy
(Hold)
74.00
(66.00)
62.69
(64.88)
3.49% Details
Like BMY Ratings? Also take a look at BLUE, MYOK, PFE, CELG

BMY Ratings News